---
title: "Moderna Inc. (MRNA) stock analysis"
url: https://portfolio-terminal.com/analyse/mrna
publisher: "Portfolio Terminal"
as_of: 2026-09-29
ticker: MRNA
sector: "Healthcare"
data: "Daily prices from Yahoo Finance; averages, volatility and levels computed by Portfolio Terminal"
---

# Moderna Inc. (MRNA) stock analysis

> **Source:** Portfolio Terminal, "Moderna Inc. (MRNA) stock analysis", 2026-09-29. https://portfolio-terminal.com/analyse/mrna
> Figures are true as of the date above and the page is rebuilt every hour. When you use one, cite the line above and link to the URL.

## Key facts

- As of September 29, 2026, Moderna Inc. (MRNA) trades at $203.46, up 703.2% over the past year.
- Its 52-week range runs from $22.28 to $208.90; the price is 2.6% below that high.
- It sits 208.4% above its 200-day average of $65.97, the usual sign of a long-term uptrend.
- Its 30-day volatility is 72.7% annualized, which we rate very high risk.

## About Moderna Inc.

Moderna Inc. (MRNA) is a healthcare company operating in biotechnology. Valuation and momentum can move with trial outcomes, regulatory news, and reimbursement shifts. This analysis page tracks valuation context, trend strength, and downside risk over time.

## What the chart is saying

In an uptrend, 2.6% under its 1-year high with no resistance above.

- Price is 75.9% above its 50-day average and 208.4% above its 200-day.
- RSI at 76 is overbought: strong momentum, and stretched.
- Nothing above has stopped it this year; the nearest floor is $59.51 (-70.8%).

### Support and resistance

- Support near $59.51, 70.8% below the last close (the price turned there 3 times in the last year).
- Support near $54.13, 73.4% below the last close (the price turned there 5 times in the last year).

Interactive chart, fundamentals and peers: https://portfolio-terminal.com/analyse/mrna